Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Felix Datlinger, ARVO 2021: Teleangiectatic Capillaries in Diabetic Macular Oedema

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jun 3rd 2021

We were pleased to speak with Felix Datlinger (Medical University of Vienna, Vienna, Austria) about teleangiectatic capillaries in diabetic macular oedema and their clinical significance.

Questions

  1. How common are teleangiectatic capillaries in diabetic macular edema and what is their clinical significance? (00:25)
  2. How are teleangiectatic capillaries diagnosed and treated? (01:04)
  3. What are the limitations in the diagnosis and treatment of teleangiectatic capillaries? (01:42)

Speaker Disclosure: Felix Datlinger has no financial or non-financial relationships or activities to declare in relation to this interview.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Lisa Glass.

Filmed in coverage of ARVO 2021.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup